This Chinese pharmaceutical company's share more than doubled in Hong Kong on Wednesday following positive news of its trial of a new Covid-19 treatment drug. Michelle Martin has the name.

Market View: Netflix, Bonds & Capital Wars - When Markets Blink
22:36

Money and Me: Beyond the Magnificent 7 - Where the Next Winners Hide
17:38

Money and Me: Asia at the Crossroads - AI, Valuations and What Really Matters in 2026
22:19